Iron absorption in patients with Zollinger-Ellison syndrome treated with long-term gastric acid antisecretory therapy

Alimentary Pharmacology and Therapeutics

Volumn 12, Issue 1, 1998, Pages 83-98

  Stewart, C A ^a   Termanini, B ^a   Sutliff, V E ^a   Serrano, J ^a   Yu, F ^a   Gibril, F ^a   Jensen, R T ^a  

^a NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FERRITIN; HISTAMINE H2 RECEPTOR ANTAGONIST; IRON; OMEPRAZOLE; STOMACH SECRETION INHIBITOR; TRANSFERRIN;

ADOLESCENT; ADULT; AGED; ARTICLE; CONTROLLED STUDY; DOSE TIME EFFECT RELATION; FEMALE; HUMAN; IRON ABSORPTION; IRON DEFICIENCY; IRON KINETICS; MAJOR CLINICAL STUDY; MALE; MEAN CORPUSCULAR HEMOGLOBIN; MEAN CORPUSCULAR VOLUME; PATIENT MONITORING; PRIORITY JOURNAL; STOMACH ACID SECRETION; ZOLLINGER ELLISON SYNDROME;

ADOLESCENT; ADULT; AGED; ANEMIA; ANTACIDS; ANTI-ULCER AGENTS; CLINICAL PROTOCOLS; FEMALE; GASTRIC ACID; HISTAMINE H2 ANTAGONISTS; HUMANS; INTESTINAL ABSORPTION; IRON; MALE; MIDDLE AGED; NATIONAL INSTITUTES OF HEALTH (U.S.); OMEPRAZOLE; UNITED STATES; ZOLLINGER-ELLISON SYNDROME;

EID: 0031963940     PISSN: 02692813     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2036.1998.00274.x     Document Type: Article

References (68)

1. Arnold R. Safety of proton pump inhibitors - an overview. Aliment Pharmacol Ther 1994; 8: 65-70.
2. Maton P. Risks of hypergastrinemia. Dig Dis Sci 1995; 13: 1-2.
3. Walt RP, Gomes MD, Wood EC, Logan LH, Pounder RE. Effect of daily oral omeprazole on 24 hour intragastric acidity. Br Med J 1983; 287: 12-14.
4. Prichard PJ, Yeomans ND, Mihaly GW, et al. Omeprazole: a study of its inhibition of gastric pH and oral pharmacokinetics after morning or evening dosage. Gastroenterology 1985; 88: 64-9.
5. Jansen JB, Klinkenberg-Knol EC, Meuwissen SG, et al. Effect of long-term treatment with omeprazole on serum gastrin and serum group A and C pepsinogens in patients with reflux esophagitis. Gastroenterology 1990; 99: 621-8.
6. Lamberts R, Creutzfeldt W, Struber HG, Brunner G, Solcia E. Long-term omeprazole therapy in peptic ulcer disease: gastrin, endocrine cell growth, and gastritis. Gastroenterology 1993; 104: 1356-70.
7. Freston JW. Clinical significance of hypergastrinaemia: relevance to gastrin monitoring during omeprazole therapy. Digestion 1992; 51: 102-14.
8. Ekman L, Hansson E, Havu N, Carlsson E, Lundberg C, Toxicological studies on omeprazole. Scand J Gastroenterol 1985; 20(Suppl. 108): 53-69.
9. 12 malabsorption and omeprazole therapy. J Am Coll Nutr 1994; 13: 544-5.
10. 12 during prolonged omeprazole therapy. J Clin Gastroenterol 1992; 14: 288-92.
11. 12 absorption. J Am Coll Nutr 1994; 13: 584-91.
12. Skikne BS, Lynch SR, Cook JD. Role of gastric acid in food iron absorption. Gastroenterology 1981; 81: 1068-71.
13. Koop H. Review article: metabolic consequences of long-term inhibition of acid secretion by omeprazole. Aliment Pharmacol Ther 1992; 6: 399-406.
14. Jacobs A, Rhodes J, Peters DK, Campbell H, Eakins JD. Gastric acidity and iron absorption. Br J Haematol 1966; 12: 728-36.
15. Jacobs P, Bothwell T, Charlton RW. Role of hydrochloric acid in iron absorption. J Appl Physiol 1964; 19: 187-8.
16. 12 levels in patients with Zollinger-Ellison syndrome. Gastroenterology 1995; 108: A226 (Abstract).
17. Conrad ME. Iron absorption. In: Johnson LR, ed. Physiology of the Gastrointestinal Tract. 2nd edn. New York: Raven Press, 1987: 1437-53.
18. Turnberg LA, Riley SA. Digestion and absorption of nutrients and vitamins. In: Sleisenger MH, Fordtran JS, eds. Gastrointestinal Disease. 5th edn. Philadelphia: W. B. Saunders, 1993: 977-1008.
19. Rucker RB, Lonnerdal B, Keen CL. Intestinal absorption of nutritionally important trace elements. In: Johnson LR, ed. Physiology of the Gastrointestinal Tract. 3rd edn. New York: Raven Press, 1994: 2183-202.
20. Charlton RW, Bothwell TH. Iron absorption. Ann Rev Med 1983; 34: 55-68.
21. Wheby MS, Crosby WH. The gastrointestinal tract and iron absorption. Blood 1963; 22: 416-28.
22. Conrad ME, Schade SG. Ascorbic acid chelates in iron absorption: a role for hydrochloric acid and bile. Gastroenterology 1968; 55: 35-45.
23. Schade SG, Cohen RJ, Conrad ME. The effect of hydrochloric acid on iron absorption. N Engl J Med 1968; 279: 672-4.
24. Bezwoda W, Charlton R, Bothwell T, Torrance J, Mayet F. The importance of gastric hydrochloric acid in the absorption of nonheme food iron. J Lab Clin Med 1978; 92: 108-16.
25. Williams J. The effect of ascorbic acid on iron absorption in post-gastrectomy anaemia and achlorhydria. Clin Sci 1959; 18: 521-5.
26. Goldberg A, Lochhead AC, Dagg JH. Histamine-fast achlorhydria and iron absorption. Lancet 1963; i: 848-50.
27. Cook JD, Brown GM, Valberg LS. The effect of achlyia gastrica on iron absroption. J Clin Invest 1964; 43: 1185-91.
28. Golubov J, Flanagan P, Adams P. Inhibition of iron absorption by omeprazole in rat model. Dig Dis Sci 1991; 36: 405-8.
29. Hines JD, Hoffbrand AV, Mollin DL. The hematologic complications following partial gastrectomy. A study of 292 patients. Am J Med 1967; 43: 555-69.
30. Wheldon EJ, Venables CW, Johnston ID. Late metabolic sequelae of vagotomy and gastroenterostomy. Lancet 1970; i: 437-40.
31. Turnberg LA. The absorption of iron after partial gastrectomy. Q J Med 1966; 35: 107-18.
32. Hobbs JR. Iron deficiency after partial gastrectomy. Gut 1961; 7: 141-9.
33. Wallensten S. Results of the surgical treatment of peptic ulcer by partial gastrectomy according to billroth I and II methods: Supplementum 191. Acta Chir Scand. 1954: 1-157.
34. Metz DC, Jensen RT. Advances in gastric antisecretory therapy in Zollinger-Ellison syndrome. In: Mignon M, Jensen RT, eds. Endocrine Tumors of the Pancreas: Recent Advances in Research and Management. Series: Frontiers of Gastrointestinal Research. Basel, Switzerland: S. Karger, 1995: 240-57.
35. Magnusson BEO. Iron absorption after antrectomy with gastroduodenostomy. Scand J Haematology 1976: (Suppl. 26): 1-107.
36. 12. Q J Med 1962; 31: 89-102.
37. Jensen RT, Gardner JD, Gastrinoma. In: Go VLW, DiMagno EP, Gardner JD, Lebenthal E, Reber HA, Scheele GA, eds. The Pancreas: Biology, Pathobiology and Disease. 2nd edn. New York: Raven Press, 1993: 931-78.
38. Fishbeyn VA, Norton JA, Benya RV. et al. Assessment and prediction of long-term cure in patients with Zollinger-Ellison syndrome: the best approach. Ann Intern Med 1993; 119: 199-206.
39. Benya RV, Metz DC, Venzon DJ, et al. Zollinger-Ellison syndrome can be the initial endocrine manifestation in patients with multiple endocrine neoplasia-type 1. Am J Med 1994; 97: 436-44.
40. Orbuch M, Doppman JL, Strader DB, et al. Imaging for pancreatic endocrine tumor localization: recent advances. In: Mignon M, Jensen RT, eds. Endocrine Tumors of the Pancreas: Recent Advances in Research and Management. Series: Frontiers of Gastrointestinal Research. Basel, Switzerland: S. Karger, 1995: 268-81.
41. Sugg SL, Norton JA, Fraker DL, et al. A prospective study of intraoperative methods to diagnose and resect duodenal gastrinomas. Ann Surg 1993; 218: 138-44.
42. Gibril F, Reynolds JC, Doppman JL, et al. Somatostatin receptor scintigraphy: its sensitivity compared with that of other imaging methods in detecting primary and metastatic gastrinomas: a prospective study. Ann Intern Med 1996; 125: 26-34.
43. Cook JD. Iron-deficiency anaemia. Bailliere's Clin Haematol 1994; 7: 787-804.
44. Guyatt GH, Oxman AD, Ali M, Willan A, McIlroy W, Patterson C. Laboratory diagnosis of iron-deficiency anemia: An overview. J Gen Intern Med 1992; 7: 145-53.
45. Hastka J, Lasserre JJ, Schwarzbeck A, Reitter A, Hehlmann R. Laboratory tests of iron status: correlation or common sense? Clin Chem 1996; 42: 718-24.
46. Cook JD, Lipschitz DA, Miles LEM, Finch CA. Serum ferritin as a measure of iron stores in normal subjects. Am J Clin Nutr 1974; 27: 681-7.
47. Walters GO, Miller FM, Worwood M. Serum ferritin concentration and iron stores in normal subjects. J Clin Path 1973; 26: 770-2.
48. Lipschitz DA, Cook JD, Finch CA. A clinical evaluation of serum ferritin as an index of iron stores. N Engl J Med 1974; 290: 1213-16.
49. Skoog DP. Laboratory evaluation of iron deficiency. In: Bick RL, ed. Hematology. St. Louis: Mosby Yearbook, 1993: 273-9.
50. Cook JD. Clinical evaluation of iron deficiency. Semin Hematol 1982; 19: 6-18.
51. Baird IM, Blackburn EK, Wilson GM. The pathogenesis of anaemia after partial gastrectomy. I. Development of anaemia in relation to time after operation, blood loss, and diet. Q J Med 1959; 109: 21-34.
52. Jacobs A. Effect of gastric juice and pH on inorganic iron in solution. Nature 1967; 216: 707-8.
53. Jacobs A, Miles PM. Role of gastric secretion in iron absorption. Gut 1969; 10: 226-9.
54. Minot GR, Heath GW. The response of reticulocytes to iron. Am J Med Sci 1932; 183: 110-18.
55. Baird IM, Wilson GM. The pathogenesis of anaemia after partial gastrectomy. II. Iron absorption after partial gastrectomy. Q J Med 1959; 109: 35-41.
56. Choudhury MR, Williams J. Iron absorption and gastric operations. Clin Sci 1959; 18: 527-32.
57. Shafer RB, Ripley D, Swaim WR, Mahmud K, Doscherholmen A. Hematologic alterations following partial gastrectomy. Am J Med Sci 1973; 266: 240-8.
58. Brookes VS, Meynell MJ, Bold AM, Kingston RD. A review of symptoms, haematology and clinical chemistry following a partial gastrectomy. Br J Surg 1974; 61: 9-15.
59. Svensson A. Vagotomy with antrum resection. Acta Chir Scand 1974; 140: 50-6.
60. Wastell C. Long-term clinical and metabolic effects of vagotomy with either gastrojejunostomy or pyloroplasty. Ann R Coll Surg Engl 1969; 45: 193-211.
61. Wastell C. Metabolic effects of vagotomy and gastric drainage. Postgrad Med J 1967; 43: 481-6.
62. Baron JH. Selective surgery for duodenal ulcer. In: Clinical Tests of Gastric Secretion History. Methodology and Interpretation. New York: Oxford University Press, 1979: 152-263.
63. Rovelstad RA, Maher FT, Adson MA. Gastric analysis. Surg Clin North Am 1971; 51: 969-78.
64. Talstad I, Fretheim B, Myren J, Gjone E, Holler O. Graded gastrectomy for duodenal ulcer - a live-year prospective study. Scand J Gastroenterol 1975; 33(Suppl.): 1-27.
65. Myren J, Gjeruldsen S, Fretheim B. Gastric secretion before and after graded partial gastrectomy for duodenal ulcer. Scand J Gastroenterol 1966; 1: 132-7.
66. Thompson JC, Fender HR, Watson LC, Villar HV. The effects on gastrin and gastric secretion of live current operations for duodenal ulcer. Ann Surg 1976; 185: 599-608.
67. Aoyagi T, Summerskill WH. Gastric secretion with ulcerogenic islet cell tumor. Importance of basal acid output. Arch Intern Med 1966; 117: 667-72.
68. Wintrobe MM. Clinical Haematology. 4th edn. London: Kimpton, 1956.